FMR LLC 13D and 13G filings for Tyra Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 10:43 am Sale | 2025-03-31 | 13G | Tyra Biosciences, Inc. TYRA | FMR LLC | 1,707,148 3.200% | -1,665,702 (-49.39%) | Filing |
| 2024-11-12 10:34 am Sale | 2024-11-08 | 13G | Tyra Biosciences, Inc. TYRA | FMR LLC | 3,372,850 6.387% | -1,281,426 (-27.53%) | Filing |
| 2024-03-11 08:19 am Purchase | 2024-03-08 | 13G | Tyra Biosciences, Inc. TYRA | FMR LLC | 4,654,276 10.809% | 1,885,580 (+68.10%) | Filing |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | Tyra Biosciences, Inc. TYRA | FMR LLC | 2,768,696 6.430% | -1,110,427 (-28.63%) | Filing |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | Tyra Biosciences, Inc. TYRA | FMR LLC | 3,879,123 9.192% | 410,292 (+11.83%) | Filing |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | Tyra Biosciences, Inc. TYRA | FMR LLC | 3,468,831 8.406% | 3,468,831 (New Position) | Filing |